A woman in Washington, D.C. has filed a lawsuit against Bayer as a result of a stroke that occurred from taking the birth control product called Yaz. In early 2008, Sharon Paez, the plaintiff, was prescribed Yaz by her health care provider which she took as a contraceptive but also as treatment for other menstrual complaints such as acne, cramps, and PMS.
The drug debuted on the American market in 2001. Yaz and sister products Yasmin and Ocella are marked similarly to other oral contraceptives widely available in the United States, however they contain drospirenone, a type of progestin not found in any other birth control in the United States.
Paez believes that as a result of years of taking Yaz, she suffered a stroke. She continues to suffer from pain and suffering, various physical injuries, disability, significant disfigurement, embarrassment, mental anguish, loss of capacity, for the enjoyment of life, expenses of hospitalization, medical and nursing care treatment, loss of earnings, loss of ability to earn money in the future, and a shortened life span.
Paez alleges that Bayer Pharmaceuticals’ failure to warn her and other consumers of the dangers of Yaz that puts the company at fault for negligence, design defect, false advertising, defective warning, and loss. She is seeking $750,000 in damages and compensation for her pain and suffering.
This lawsuit follows the litany of other class action suits regarding contraceptive products including NuvaRing and Mirena IUD.